We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $976M
1-Year Est. Return 66.76%
This Fund
S&P 500
This Quarter Est. Return
+29.1%
1 Year Est. Return
+66.76%
3 Year Est. Return
+217.15%
5 Year Est. Return
+352.97%
10 Year Est. Return
+2,412.55%
AUM
$976M
AUM Growth
+$65.1M
Cap. Flow
+$24.5M
Cap. Flow %
2.51%
Top 10 Hldgs %
37.09%
Holding
100
New
33
Increased
11
Reduced
19
Closed
26

Sector Composition

Rank Sector Weight
1 Healthcare 25.52%
2 Miscellaneous 25.09%
3 Technology 18.45%
4 Industrials 16.44%
5 Consumer Discretionary 6.87%

No holdings matched the selected filter criteria.

Similar funds

Kingdon Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Kingdon Capital Management held 100 positions worth $976M, up 7.2% from $911M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Kingdon Capital Management's Q2 2026 filing shows 33 new, 11 increased, 19 reduced and 26 closed positions. Its largest new stake was GRAIL Inc: 340,000 shares worth $23.2M. The largest sale was Soleno Therapeutics, an estimated $19.3M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Technology.

  • Kingdon Capital Management's largest Q2 2026 buy was GRAIL Inc: 340,000 shares worth $23.2M.
  • Kingdon Capital Management added most to NVIDIA in Q2 2026, an estimated $8.22M increase.
  • Kingdon Capital Management's biggest Q2 2026 reduction was Flex, cutting an estimated $10.3M.
  • Kingdon Capital Management fully exited Soleno Therapeutics in Q2 2026, selling an estimated $19.3M.
  • Kingdon Capital Management's ten largest holdings make up 37% of its $976M portfolio in Q2 2026.
  • Kingdon Capital Management opened 33 new positions and closed 26 in Q2 2026.
  • Kingdon Capital Management's portfolio value rose 7.2% quarter-over-quarter to $976M.

Based on Kingdon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.